Single-dose gene therapy has the potential to change the lives of adults with hemophilia B
Adults with hemophilia B saw their number of bleeding episodes decrease by an average of 71 percent after a single… Read More »Single-dose gene therapy has the potential to change the lives of adults with hemophilia B